News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

August 2014

Top

UK Government to provide additional £160m to Cancer Drugs Fund
29 August 2014 The UK Government is set to add an additional £160m to the Cancer Drugs Fund, in order to improve treatment for patients....

Vifor Pharma’s Velphoro gets EU marketing authorisation to treat hyperphosphatemia
29 August 2014 Vifor Pharma has received EU marketing authorisation from the European Commission for its Velphoro (sucroferric oxyhydroxide) to treat hyperphosphatemia in adult CKD patients on dialysis....

DARPA’s ElectRx programme seeks to develop new customised therapies
28 August 2014 The US Defense Advanced Research Projects Agency (DARPA) has designed new electrical prescriptions (ElectRx) programme, to develop new high-precision and minimally invasive technologies to...

FDA clears GSK’s Promacta sNDA to treat SAA patients
28 August 2014 The US Food and Drug Administration (FDA) has given its clearance to supplemental new drug application (sNDA) for GlaxoSmithKline's (GSK) Promacta (eltrombopag) to treat patients with...

FDA grants orphan drug designation to Insys’ cannabidiol to treat GBM
27 August 2014 Insys Therapeutics has obtained orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for its pharmaceutical cannabidiol (CBD) to treat glioblastoma multiforme (GBM),...

Venus signs agreement with Teva Canada to develop anti-cancer drug
27 August 2014 India-based Venus Remedies has signed a collaborative agreement with Teva Canada for an anti-cancer drug, which is under patent protection until 2016....

Alkermes submits new drug application for aripiprazole to treat Schizophreni
26 August 2014 The US Food and Drug Administration (FDA) has received a new drug application (NDA) from Ireland-based Alkermes for its aripiprazole lauroxil to treat...

Roche to acquire InterMune for $8.3bn
26 August 2014 Swiss drugmaker Roche has signed a definitive merger agreement to acquire InterMune for around...

CMDh recommends restricted use of bromocriptine to suppress lactation
22 August 2014 The Coordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) has recommended the restricted use of bromocriptine to prevent or suppress breast milk...

Sunovion introduces new oral treatment Latuda for schizophrenia in UK
22 August 2014 Sunovion Pharmaceuticals Europe has revealed that Latuda (lurasidone), a new once-daily oral treatment, is available in the UK to treat schizophrenia in...

NICE recommends Celgene’s Revlimid to treat myelodysplastic syndromes
21 August 2014 The UK National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Celgene's Revlimid (lenalidomide) to treat myelodysplastic syndromes...

UK launches new Ebola research initiative
21 August 2014 The Wellcome Trust and the Department for International Development (DFID) have launched a new research initiative to restrict the spread of Ebola, which has claimed the lives of...

Garvan and Roche to develop new technologies for targeted epigenomic analysis
21 August 2014 The Garvan Institute of Medical Research has collaborated with Roche Sequencing to develop new technologies for targeted epigenomic analysis using DNA...

Novartis signs exclusive worldwide licensing agreement with TB Alliance
20 August 2014 Swiss pharmaceutical firm Novartis has entered into an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development (TB Alliance), to provide drug candidate compounds...

Pfizer submits new drug application to FDA for breast cancer palbociclib drug
20 August 2014 US-based pharmaceutical company Pfizer has submitted a new drug application (NDA) for palbociclib to the US Food and Drug Administration...

AWMSG recommends Bayer’s Sativex to treat multiple sclerosis
19 August 2014 The All Wales Medicines Strategy Group (AWMSG) has recommended Bayer Healthcare’s Sativex Oromucosal Spray for symptom improvement in adult patients with moderate to severe spasticity due...

Roche’s Avastin plus chemotherapy receives FDA approval to treat cervical cancer
18 August 2014 Switzerland-based Roche has received approval from the US Food and Drug Administration (FDA) for its Avastin (bevacizumab), in combination with paclitaxel and cisplatin or paclitaxel and...

FDA approves Biogen’s Plegridy to treat multiple sclerosis
18 August 2014 Biotechnology firm Biogen Idec has received approval from the US Food and Drug Administration (FDA) for its Plegridy (peginterferon beta-1a) to treat people with relapsing forms of...

Merck’s Belsomra receives FDA approval to treat insomnia
15 August 2014 Merck has received approval from the US Food and Drug Administration (FDA) for its Belsomra (suvorexant) to treat insomnia in adults having difficulty falling asleep and/or staying...

AWMSG recommends GSK’s Relvar Ellipta to treat asthma
15 August 2014 All Wales Medicines Strategy Group (AWMSG) has recommended British drug-maker GlaxoSmithKline's (GSK) Relvar Ellipta to treat patients with asthma within NHS Wales, following the receipt...

Sanofi introduces authorised generic version of Eloxatin
14 August 2014 Sanofi US has introduced an authorised generic version of Eloxatin (oxaliplatin injection), a platinum-based drug used in combination with infusional 5-fluorouracil /...